Miller, Robert J. H.
Singh, Ananya
Otaki, Yuka
Tamarappoo, Balaji K.
Kavanagh, Paul
Parekh, Tejas
Hu, Lien-Hsin
Gransar, Heidi
Sharir, Tali
Einstein, Andrew J.
Fish, Mathews B.
Ruddy, Terrence D.
Kaufmann, Philipp A.
Sinusas, Albert J.
Miller, Edward J.
Bateman, Timothy M.
Dorbala, Sharmila
Di Carli, Marcelo F.
Liang, Joanna X.
Dey, Damini
Berman, Daniel S.
Slomka, Piotr J.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01HL089765, R35HL161195)
Article History
Received: 24 June 2022
Accepted: 15 September 2022
First Online: 4 October 2022
Declarations
:
: The study protocol complied with the Declaration of Helsinki and was approved by the institutional review boards at each participating institution and the overall study was approved by the institutional review board at Cedars-Sinai Medical Center.
: Drs. Berman and Slomka and Mr. Kavanagh participate in software royalties for QPS software at Cedars-Sinai Medical Center. Dr. Slomka has received research grant support from Siemens Medical Systems. Drs. Berman is serving as a consultant for GE Healthcare (radiopharmaceuticals). Dorbala, Einstein, and Edward Miller have served as consultants for GE Healthcare. Dr. Einstein has served as a consultant to W. L. Gore and Associates. Dr. Dorbala has served as a consultant to Bracco Diagnostics; her institution has received grant support from Astellas. Dr. Di Carli has received research grant support from Spectrum Dynamics and consulting honoraria from Sanofi and GE Healthcare. Dr. Ruddy has received research grant support from GE Healthcare and Advanced Accelerator Applications. Dr. Einstein’s institution has received research support from GE Healthcare, Philips Healthcare, Toshiba America Medical Systems, Roche Medical Systems, and W. L. Gore and Associates. The remaining authors have nothing to disclose.